{"hands_on_practices": [{"introduction": "In pathology and epidemiology, observing an association between a potential risk factor and a disease is only the first step. This exercise [@problem_id:4429358] delves into the critical distinction between association and causation by analyzing a hypothetical link between Bacterial Vaginosis (BV) and Pelvic Inflammatory Disease (PID). You will practice calculating fundamental measures like relative risk and population attributable fraction, which quantify the strength of an association and its public health impact, while also confronting the rigorous assumptions needed to interpret these findings causally.", "problem": "A prospective observational cohort of sexually active women aged $18$ to $35$ years is assembled to study the relationship between Bacterial Vaginosis (BV) and Pelvic Inflammatory Disease (PID). At baseline, BV status is assessed, and participants are followed for $1$ year to ascertain incident PID. Empirically, the baseline prevalence of BV is $30\\%$, the $1$-year incidence of PID among those with BV at baseline is $3\\%$, and the $1$-year incidence of PID among those without BV at baseline is $1\\%$. Using only core epidemiologic definitions and the law of total probability, do the following: \n- From first principles, derive the relative risk comparing BV to non-BV and then derive an expression for the fraction of incident PID cases in the population that is attributable to BV, assuming the exposure (BV) could be eliminated without otherwise altering the outcome-generating mechanism.\n- Clearly articulate the causal assumptions under which the relative risk and the attributable fraction can be interpreted causally rather than purely associational.\n\nReport as your final numeric output the population attributable fraction (unitless) as a decimal. Round your final answer to $4$ significant figures and express it without a percent sign.", "solution": "The problem requires the derivation of key epidemiologic measures and an explication of the assumptions undergirding their causal interpretation, followed by a numerical calculation. We begin by formalizing the problem statement.\n\nLet $E$ denote the event that a woman has Bacterial Vaginosis (BV) at baseline (the exposure).\nLet $\\bar{E}$ denote the event that a woman does not have BV at baseline (no exposure).\nLet $D$ denote the event that a woman develops Pelvic Inflammatory Disease (PID) during the $1$-year follow-up period (the disease outcome).\n\nFrom the problem statement, we are given the following probabilities:\n- The baseline prevalence of BV: $P(E) = 0.30$.\n- The prevalence of no BV is therefore: $P(\\bar{E}) = 1 - P(E) = 1 - 0.30 = 0.70$.\n- The $1$-year incidence (risk) of PID among women with BV: $P(D|E) = 0.03$. This is the risk in the exposed, which we can denote as $R_E$.\n- The $1$-year incidence (risk) of PID among women without BV: $P(D|\\bar{E}) = 0.01$. This is the risk in the unexposed, which we can denote as $R_{\\bar{E}}$.\n\n**Derivation of Relative Risk (RR)**\nThe relative risk is a measure of association defined as the ratio of the incidence of the outcome in the exposed group to the incidence of the outcome in the unexposed group.\nUsing the terminology defined above:\n$$\nRR = \\frac{\\text{Risk in exposed}}{\\text{Risk in unexposed}} = \\frac{R_E}{R_{\\bar{E}}}\n$$\nSubstituting the probabilistic notation:\n$$\nRR = \\frac{P(D|E)}{P(D|\\bar{E})}\n$$\nThis expression represents the derived formula for relative risk based on core epidemiologic definitions.\n\n**Derivation of Population Attributable Fraction (PAF)**\nThe population attributable fraction (PAF) represents the proportion of incident cases in the total population that is \"attributable\" to the exposure. To derive this, we must first determine the overall incidence of PID in the entire cohort, denoted $P(D)$. Using the law of total probability, we can express $P(D)$ by conditioning on the exposure status:\n$$\nP(D) = P(D|E)P(E) + P(D|\\bar{E})P(\\bar{E})\n$$\nThis equation states that the total risk in the population is the weighted average of the risks in the exposed and unexposed strata, with the weights being the prevalence of each stratum.\n\nThe core idea behind attributable risk is to quantify the excess disease burden in a population due to the exposure. This requires a counterfactual comparison: we compare the current incidence in the population, $P(D)$, with the incidence that would be observed if the exposure were to be eliminated from the population. Assuming that eliminating the exposure would reduce the risk of everyone to the baseline level seen in the unexposed, this counterfactual incidence is $P(D|\\bar{E})$.\n\nThe excess incidence in the population due to the exposure is the population attributable risk (PAR):\n$$\nPAR = P(D) - P(D|\\bar{E})\n$$\nThe population attributable fraction is this excess incidence expressed as a fraction of the total incidence in the population:\n$$\nPAF = \\frac{PAR}{P(D)} = \\frac{P(D) - P(D|\\bar{E})}{P(D)}\n$$\nThis is the required expression for the population attributable fraction, derived from first principles. By substituting the law of total probability for $P(D)$, we can also write it as:\n$$\nPAF = \\frac{\\left( P(D|E)P(E) + P(D|\\bar{E})P(\\bar{E}) \\right) - P(D|\\bar{E})}{P(D|E)P(E) + P(D|\\bar{E})P(\\bar{E})}\n$$\n\n**Causal Assumptions**\nFor the associational measures derived above (RR and PAF) to be interpreted causally, several critical assumptions must hold. A causal interpretation implies that the RR represents the factor by which the risk of PID would be multiplied if an individual were exposed to BV versus not, and the PAF represents the proportion of PID cases that would be prevented if BV were eliminated.\n\n1.  **Exchangeability (No Confounding):** This is the most crucial assumption. It requires that the unexposed group is a valid surrogate for the counterfactual experience of the exposed group, had they not been exposed. In other words, the risk of PID in the unexposed group, $P(D|\\bar{E})$, must be equal to the risk of PID that the exposed group would have had if they had not had BV. Formally, using potential outcomes notation where $D_e$ is the outcome if exposed and $D_{\\bar{e}}$ is the outcome if unexposed, exchangeability means $P(D_{\\bar{e}}|E) = P(D_{\\bar{e}}|\\bar{E})$. Any factor (e.g., sexual behavior, contraceptive use, immune status) that is associated with both BV and the risk of PID and is not on the causal pathway can act as a confounder, violating exchangeability. In an observational study, this assumption is often not met without statistical adjustment for confounders.\n\n2.  **Positivity:** For every combination of confounders, there must be both exposed and unexposed individuals. This ensures that a comparison is possible across all relevant strata of the population. In this problem, positivity is met as there are both women with BV ($P(E)=0.30$) and without BV ($P(\\bar{E})=0.70$).\n\n3.  **Consistency (and No Interference):** This assumption, often part of the Stable Unit Treatment Value Assumption (SUTVA), has two parts. First, an individual's potential outcome is not affected by the exposure status of other individuals (no interference). Second, the exposure (BV) is sufficiently well-defined so that the outcome under exposure does not depend on how an individual came to be exposed (consistency). The assumption is that setting the entire population's BV status to \"absent\" would result in a uniform risk profile equal to $R_{\\bar{E}}$.\n\nIf these assumptions hold, the associative RR estimates the causal risk ratio, and the associative PAF estimates the true fraction of disease that would be averted by eliminating the exposure.\n\n**Calculation of the Population Attributable Fraction**\nFirst, we calculate the overall incidence of PID in the population, $P(D)$:\n$$\nP(D) = P(D|E)P(E) + P(D|\\bar{E})P(\\bar{E}) = (0.03)(0.30) + (0.01)(0.70)\n$$\n$$\nP(D) = 0.009 + 0.007 = 0.016\n$$\nNext, we use the derived formula for PAF:\n$$\nPAF = \\frac{P(D) - P(D|\\bar{E})}{P(D)} = \\frac{0.016 - 0.01}{0.016}\n$$\n$$\nPAF = \\frac{0.006}{0.016} = \\frac{6}{16} = \\frac{3}{8} = 0.375\n$$\nThe problem requires the final answer to be rounded to $4$ significant figures.\n$$\nPAF = 0.3750\n$$", "answer": "$$\\boxed{0.3750}$$", "id": "4429358"}, {"introduction": "The clinical utility of a diagnostic test is not defined by its sensitivity and specificity alone, but by how it performs in a real-world population and influences treatment decisions. This problem [@problem_id:4429399] guides you through the process of evaluating a clinical decision rule for PID by calculating its positive and negative predictive values ($PPV$ and $NPV$). By applying these post-test probabilities against a defined treatment threshold, you will gain practical insight into the evidence-based rationale for initiating empiric therapy.", "problem": "A point-of-care clinical decision rule for Pelvic Inflammatory Disease (PID) is applied to a population of symptomatic reproductive-age patients in whom the pretest probability (prevalence) of PID is $\\pi = 0.10$. In a validation study, the ruleâ€™s sensitivity is $Se = 0.80$ and specificity is $Sp = 0.70$. Using only the foundational definitions of sensitivity, specificity, prevalence, and conditional probability from probability theory and epidemiology, derive expressions for the positive predictive value (PPV) and negative predictive value (NPV), and then compute their numerical values for these parameters. Then, using a decision threshold for empiric antibiotic treatment of $\\tau = 0.20$ applied to the post-test probability after a positive result, discuss whether a positive result justifies empiric treatment at the point of care, and whether a negative result sufficiently lowers disease probability to defer empiric treatment, grounding your reasoning in the consequences of missed PID versus overtreatment. Report your final numerical answers for PPV and NPV in the order PPV, NPV as decimals, rounded to four significant figures. Do not use a percentage sign.", "solution": "Let $D$ be the event that a patient has Pelvic Inflammatory Disease (PID), and let $D^c$ be the event that the patient does not have PID. Let $T^+$ be the event of a positive test result and $T^-$ be the event of a negative test result.\n\nThe givens from the problem statement are translated into probabilistic terms as follows:\nThe pretest probability, or prevalence, is $\\pi = P(D) = 0.10$.\nThe probability of not having the disease is therefore $P(D^c) = 1 - P(D) = 1 - 0.10 = 0.90$.\nThe sensitivity of the test is $Se = P(T^+|D) = 0.80$. This is the probability of a positive test given the patient has the disease.\nThe specificity of the test is $Sp = P(T^-|D^c) = 0.70$. This is the probability of a negative test given the patient does not have the disease.\n\nFrom these definitions, we can also derive two other conditional probabilities:\nThe false negative rate is $P(T^-|D) = 1 - P(T^+|D) = 1 - Se = 1 - 0.80 = 0.20$.\nThe false positive rate is $P(T^+|D^c) = 1 - P(T^-|D^c) = 1 - Sp = 1 - 0.70 = 0.30$.\n\nThe task is to derive and compute the Positive Predictive Value (PPV) and the Negative Predictive Value (NPV).\n\nThe PPV is the post-test probability of having the disease given a positive test result, defined as $PPV = P(D|T^+)$. We use Bayes' theorem to derive the expression for PPV:\n$$PPV = P(D|T^+) = \\frac{P(T^+|D)P(D)}{P(T^+)}$$\nThe denominator, $P(T^+)$, is the total probability of a positive test result, which can be found using the law of total probability:\n$$P(T^+) = P(T^+|D)P(D) + P(T^+|D^c)P(D^c)$$\nSubstituting the symbols for sensitivity, specificity, and prevalence:\n$$P(T^+) = (Se)(\\pi) + (1 - Sp)(1 - \\pi)$$\nThus, the general expression for PPV is:\n$$PPV = \\frac{(Se)(\\pi)}{(Se)(\\pi) + (1 - Sp)(1 - \\pi)}$$\nNow, we substitute the given numerical values:\n$$PPV = \\frac{(0.80)(0.10)}{(0.80)(0.10) + (1 - 0.70)(1 - 0.10)} = \\frac{0.08}{0.08 + (0.30)(0.90)} = \\frac{0.08}{0.08 + 0.27} = \\frac{0.08}{0.35}$$\n$$PPV = \\frac{8}{35} \\approx 0.228571$$\nRounding to four significant figures, $PPV \\approx 0.2286$.\n\nThe NPV is the post-test probability of not having the disease given a negative test result, defined as $NPV = P(D^c|T^-)$. We use Bayes' theorem again:\n$$NPV = P(D^c|T^-) = \\frac{P(T^-|D^c)P(D^c)}{P(T^-)}$$\nThe denominator, $P(T^-)$, is the total probability of a negative test result:\n$$P(T^-) = P(T^-|D^c)P(D^c) + P(T^-|D)P(D)$$\nSubstituting the symbols for sensitivity, specificity, and prevalence:\n$$P(T^-) = (Sp)(1 - \\pi) + (1 - Se)(\\pi)$$\nThus, the general expression for NPV is:\n$$NPV = \\frac{(Sp)(1 - \\pi)}{(Sp)(1 - \\pi) + (1 - Se)(\\pi)}$$\nNow, we substitute the given numerical values:\n$$NPV = \\frac{(0.70)(1 - 0.10)}{(0.70)(1 - 0.10) + (1 - 0.80)(0.10)} = \\frac{(0.70)(0.90)}{(0.70)(0.90) + (0.20)(0.10)} = \\frac{0.63}{0.63 + 0.02} = \\frac{0.63}{0.65}$$\n$$NPV = \\frac{63}{65} \\approx 0.969230$$\nRounding to four significant figures, $NPV \\approx 0.9692$.\n\nNext, we address the clinical decision-making part of the problem.\nA decision threshold for empiric antibiotic treatment is given as $\\tau = 0.20$.\n\nFor a positive test result, the post-test probability of disease is the PPV. We calculated $PPV \\approx 0.2286$. We compare this to the treatment threshold $\\tau$:\n$$PPV \\approx 0.2286 > \\tau = 0.20$$\nSince the post-test probability of PID exceeds the treatment threshold, a positive result from this decision rule justifies the initiation of empiric antibiotic treatment. This reflects a clinical judgment that the potential harm of missing a true case of PID (e.g., infertility, chronic pain, ectopic pregnancy) outweighs the harm of overtreatment in a patient who tests positive but does not have the disease (a false positive). Even though there is a $1 - PPV \\approx 1 - 0.2286 = 0.7714$ or $77.14\\%$ chance that a patient with a positive test does not have PID, the post-test risk of $22.86\\%$ is deemed unacceptably high to leave untreated.\n\nFor a negative test result, we must evaluate if the probability of disease is sufficiently lowered to defer treatment. The post-test probability of disease given a negative result is $P(D|T^-)$. This can be calculated as:\n$$P(D|T^-) = 1 - P(D^c|T^-) = 1 - NPV$$\nUsing our calculated value for NPV:\n$$P(D|T^-) \\approx 1 - 0.9692 = 0.0308$$\nThe test has reduced the probability of disease from the pretest level of $\\pi = 0.10$ (a $1$ in $10$ chance) to a post-test level of approximately $0.0308$ (about a $1$ in $32$ chance). This represents a significant reduction in the likelihood of disease. This post-test probability of $0.0308$ is substantially below the treatment threshold of $\\tau = 0.20$. Therefore, based on the provided decision framework, a negative result sufficiently lowers the disease probability to defer empiric treatment at the point of care. While a residual risk of approximately $3.1\\%$ remains, it falls below the specified action threshold, implying that a strategy of watchful waiting or follow-up is appropriate, as the risk of overtreatment is judged to outweigh the risk of this small probability of missed disease.", "answer": "$$\\boxed{\\begin{pmatrix} 0.2286 & 0.9692 \\end{pmatrix}}$$", "id": "4429399"}, {"introduction": "Effective medical interventions are judged not only by their ability to treat a disease but also by their power to prevent its most devastating long-term consequences. This practice [@problem_id:4429243] focuses on a primary goal of PID management: preventing tubal-factor infertility. You will calculate the Number Needed to Treat (NNT), a powerful metric that translates the effectiveness of empiric antibiotic therapy into a tangible figure, illuminating how many patients must be treated to prevent one case of this severe complication.", "problem": "Pelvic inflammatory disease (PID) is an ascending infection of the female upper genital tract that can lead to salpingitis, tubal scarring, and ultimately tubal-factor infertility. In a population of patients with suspected PID, suppose the untreated progression risk from suspected PID to tubal damage sufficient to cause infertility is $10\\%$. Empiric antibiotic therapy is instituted at the time of suspicion and reduces the progression risk by $50\\%$ relative to no treatment. Assume outcomes are independent across patients and that the treatment effect is uniform across all treated individuals.\n\nUsing only the following foundational concepts:\n- Risk is the probability of an event in a specified time frame; denote the baseline (untreated) risk as $p_{0}$.\n- A relative risk reduction is the proportion $r$ by which a treatment multiplies down the baseline risk, so the treated risk $p_{t}$ satisfies $p_{t} = p_{0} (1 - r)$.\n- The expected number of events prevented among $N$ treated patients equals $N$ times the absolute reduction in risk per patient.\n\nDerive, from these concepts, the number needed to treat (NNT) to prevent one case of tubal infertility in this population, and provide the final numerical value. Express your final answer as a number with no units. No rounding is necessary.", "solution": "The pathological endpoint of interest is tubal damage leading to infertility. Let the baseline risk (untreated) of progression to this endpoint be denoted by $p_{0}$. We are given $p_{0} = 0.10$ since $10\\%$ corresponds to $0.10$ as a probability.\n\nEmpiric antibiotic therapy reduces the progression risk by a relative amount $r$. We are given $r = 0.50$ because the reduction is $50\\%$. By the definition of relative risk reduction, the treated risk $p_{t}$ is obtained by multiplying the baseline risk by the remaining fraction after reduction:\n$$\np_{t} = p_{0} (1 - r).\n$$\nSubstituting symbols, we keep this expression in symbolic form:\n$$\np_{t} = p_{0} (1 - r).\n$$\n\nThe absolute risk reduction (ARR) per patient is the difference between the untreated and treated risks:\n$$\n\\text{ARR} = p_{0} - p_{t}.\n$$\nUsing the expression for $p_{t}$,\n$$\n\\text{ARR} = p_{0} - p_{0}(1 - r) = p_{0} \\big[1 - (1 - r)\\big] = p_{0} r.\n$$\n\nBy linearity of expectation and independence, the expected number of events prevented when treating $N$ patients is $N$ times the per-patient absolute risk reduction:\n$$\n\\text{Expected prevented events} = N \\cdot \\text{ARR} = N \\cdot p_{0} r.\n$$\nThe number needed to treat (NNT) is defined as the number $N$ for which the expected prevented events equals $1$ prevented event. Setting\n$$\nN \\cdot p_{0} r = 1\n$$\nand solving for $N$ yields\n$$\nN = \\frac{1}{p_{0} r}.\n$$\n\nNow substitute the given values $p_{0} = 0.10$ and $r = 0.50$:\n$$\nN = \\frac{1}{0.10 \\times 0.50} = \\frac{1}{0.05} = 20.\n$$\nTherefore, the number needed to treat to prevent one case of tubal-factor infertility in this population is $20$.", "answer": "$$\\boxed{20}$$", "id": "4429243"}]}